期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Synthesis and Electronic Structure of A2B Type Halogen Atoms Substituted H3-Triarylcorroles 被引量:1
1
作者 李敏智 朱卫华 +3 位作者 MACK John MKHIZE Scebi NYOKONG Tebello 梁旭 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2017年第3期367-380,共14页
Seven electron-deficient A_2 B type H_3-triarylcorroles have been synthesized and characterized. The solvent dependence of the electronic absorption and magnetic circular dichroism(MCD) spectra and a series of TD-DF... Seven electron-deficient A_2 B type H_3-triarylcorroles have been synthesized and characterized. The solvent dependence of the electronic absorption and magnetic circular dichroism(MCD) spectra and a series of TD-DFT calculations have been used to analyze trends in the electronic structures. Significant differences are observed in the optical spectra when solvents of differing polarity are used,which can be assigned to the effect of NH-tautomerism. 展开更多
关键词 a_2b type corrole solvatochromism electronic structure spectroscopy TD-DFT
在线阅读 下载PDF
新型含吡啶酮(吡唑)结构的A_(2a)/A_(2b)双靶点腺苷受体拮抗剂的合成及生物活性研究
2
作者 李志 胡代强 +2 位作者 付信珍 张淑敏 刘明 《合成化学》 CAS 2022年第9期688-696,共9页
设计并合成了具有吡啶酮或吡唑结构的6个新型双靶点(A_(2a)和A_(2b))腺苷受体拮抗剂。其结构经^(1)H NMR、^(13)C NMR和HR-MS(ESI)表征。采用cAMP法评价了目标化合物(11a~11f)对A_(2a)和A_(2b)受体的抑制活性。活性测试结果表明:该系列... 设计并合成了具有吡啶酮或吡唑结构的6个新型双靶点(A_(2a)和A_(2b))腺苷受体拮抗剂。其结构经^(1)H NMR、^(13)C NMR和HR-MS(ESI)表征。采用cAMP法评价了目标化合物(11a~11f)对A_(2a)和A_(2b)受体的抑制活性。活性测试结果表明:该系列化合物对A_(2a)和A_(2b)受体均有较好的抑制活性。其中化合物11e抑制活性最强,抑制A_(2a)和A_(2b)受体的IC_(50)值分别为8.188 nM和15.22 nM,11e对A_(2b) R受体的抑制活性优于阳性对照药AB928(IC_(50)=36.48 nM)。此外,利用分子对接研究了化合物11e与A_(2a)和A_(2b)靶点的结合情况,结果表明:化合物11e与A_(2a)和A_(2b)靶点具有较好的亲和作用。 展开更多
关键词 吡啶酮 吡唑 A_(2a)/A_(2b)双靶点 腺苷受体拮抗剂 合成 cAMP法 分子对接 生物活性
在线阅读 下载PDF
腺苷A_(2B)受体激活减轻脓毒症诱导的急性肺损伤及肺微血管内皮炎症损伤
3
作者 王慧霞 安友仲 《中国临床新医学》 2024年第2期138-144,共7页
目的分析腺苷A_(2B)受体(A_(2B) R)激活对脓毒症诱导的急性肺损伤(ALI)的影响并探讨其在肺微血管内皮炎症损伤中的调控作用。方法(1)将24只SD大鼠随机分为假手术组(sham组)、ALI模型组(ALI组)、A_(2B) R激动剂BAY60-6583干预组(ALI+BAY... 目的分析腺苷A_(2B)受体(A_(2B) R)激活对脓毒症诱导的急性肺损伤(ALI)的影响并探讨其在肺微血管内皮炎症损伤中的调控作用。方法(1)将24只SD大鼠随机分为假手术组(sham组)、ALI模型组(ALI组)、A_(2B) R激动剂BAY60-6583干预组(ALI+BAY组)和A_(2B) R抑制剂PSB1115干预组(ALI+PSB组),每组6只。制模后24 h处死大鼠取肺组织,光镜下行肺损伤评分(Smith评分),计算肺湿/干质量比值(W/D)。Evans Blue染色法测定肺水清除率(AFC)。酶联免疫吸附试验(ELISA)测定肺组织炎症因子肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)的水平。(2)采用TNF-α诱导人肺微血管内皮细胞(HPMECs)损伤模型,设立对照组、TNF-α组、BAY组、PSB组、BAY+TNF-α组和PSB+TNF-α组,各组细胞培养24 h后采用异硫氰酸荧光素(FITC)-白蛋白(albumin)法检测HPMECs单层通透性,Werstern blot法检测IL-1β、细胞间黏附分子-1(ICAM-1)、血管内皮钙黏连蛋白(VE-cadherin)、促血管生成素(ANGPT)的表达水平。结果与sham组比较,ALI组的Smith评分、肺W/D及肺组织TNF-α、IL-6、IL-1β水平均显著升高,AFC显著降低;与ALI组比较,ALI+BAY组的Smith评分、肺W/D及肺组织TNF-α、IL-6、IL-1β水平显著降低,AFC显著升高;而ALI+PSB组结果相反。TNF-α诱导HPMECs损伤模型中,与对照组比较,TNF-α组IL-1β、ICAM-1表达水平及HPMECs单层通透性升高,VE-cadherin、ANGPT表达水平降低。与TNF-α组比较,BAY+TNF-α组IL-1β、ICAM-1表达水平及HPMECs单层通透性降低,VE-cadherin、ANGPT表达水平升高,而PSB1115预处理可逆转上述现象。上述各组之间差异有统计学意义(均P<0.05)。结论腺苷A_(2B) R激活可减轻脓毒症诱导的ALI,并通过减轻肺微血管内皮炎症、降低通透性、促进血管生成等途径起保护作用。 展开更多
关键词 腺苷A_(2B)受体 脓毒症 急性肺损伤 人肺微血管内皮细胞 炎症
暂未订购
Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A_(2A/2B)receptors in tolerogenic dendritic cells 被引量:3
4
作者 Gaona Shi Yu Zhou +7 位作者 Wenshuai Liu Chengjuan Chen Yazi Wei Xinlong Yan Lei Wu Weiwei Wang Lan Sun Tiantai Zhang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第6期2778-2794,共17页
Tolerogenic dendritic cells(tol DCs)facilitate the suppression of autoimmune responses by differentiating regulatory T cells(Treg).The dysfunction of immunotolerance results in the development of autoimmune diseases,s... Tolerogenic dendritic cells(tol DCs)facilitate the suppression of autoimmune responses by differentiating regulatory T cells(Treg).The dysfunction of immunotolerance results in the development of autoimmune diseases,such as rheumatoid arthritis(RA).As multipotent progenitor cells,mesenchymal stem cells(MSCs),can regulate dendritic cells(DCs)to restore their immunosuppressive function and prevent disease development.However,the underlying mechanisms of MSCs in regulating DCs still need to be better defined.Simultaneously,the delivery system for MSCs also influences their function.Herein,MSCs are encapsulated in alginate hydrogel to improve cell survival and retention in situ,maximizing efficacy in vivo.The three-dimensional co-culture of encapsulated MSCs with DCs demonstrates that MSCs can inhibit the maturation of DCs and the secretion of pro-inflammatory cytokines.In the collagen-induced arthritis(CIA)mice model,alginate hydrogel encapsulated MSCs induce a significantly higher expression of CD39^(+)CD73^(+)on MSCs.These enzymes hydrolyze ATP to adenosine and activate A_(2A/2B)receptors on immature DCs,further promoting the phenotypic transformation of DCs to tol DCs and regulating naive T cells to Tregs.Therefore,encapsulated MSCs obviously alleviate the inflammatory response and prevent CIA progression.This finding clarifies the mechanism of MSCs-DCs crosstalk in eliciting the immunosuppression effect and provides insights into hydrogel-promoted stem cell therapy for autoimmune diseases. 展开更多
关键词 Mesenchymal stem cells Alginate hydrogel Tolerogenic dendritic cells IMMUNOTOLERANCE Adenosine A_(2A/2B)receptor CD39/CD73 Treg Rheumatoid arthritis
原文传递
Role of adenosine in tumor progression: focus on A_(2B) receptor as potential therapeutic target
5
作者 Claudia Sorrentino Silvana Morello 《Journal of Cancer Metastasis and Treatment》 CAS 2017年第1期127-138,共12页
Adenosine receptors are a family of G-coupled receptors which mediate the anti-inflammatory and immune-suppressive effects of adenosine in a damaged tissue.A large number of evidence indicate that the accumulation of ... Adenosine receptors are a family of G-coupled receptors which mediate the anti-inflammatory and immune-suppressive effects of adenosine in a damaged tissue.A large number of evidence indicate that the accumulation of adenosine under hypoxic conditions favors tumor progression,helping cancer cells to evade immune responses.Tumor cells and/or lymphoid and myeloid cells can express the adenosine-generating enzyme CD73 and/or A2A receptor,which in turn strongly suppresses an effective T-cell-mediated response,while promotes the activity of suppressive cells such as Treg and myeloid-derived suppressor cells.CD73 inhibitors and A2A antagonists,either as single agents,or in combination with immune-checkpoints inhibitors such as anti PD-1 monoclonal antibodies,are currently in Phase I clinical trial in cancer patients.Recent studies show that A2B receptor plays an important role in mediating the pro-tumor effects of adenosine,since its selective blockade can inhibit tumor growth in some murine tumor models.Targeting A2B receptor reduces immunosuppression induced by myeloid cells and inhibits the stromal cells activity within the tumor microenvironment,limiting tumor angiogenesis and metastatic processes.Here,the authors review the current data on involvement of A2B receptor in regulating tumor progression and discuss the development of A2B receptor inhibitors as potential therapeutic agents in cancer treatment. 展开更多
关键词 CD73/A_(2)adenosine receptors axis A_(2B)adenosine receptor tumor immunity tumor metastasis tumor angiogenesis cancer treatment
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部